Welcome to Lynx Bioscience

Next Generation Omics Technologies

Lynx bioscience LLC is a biotechnology outsourcing services partner (Contract Research Organization - CRO), conduct research with “OMICS” technologies. Lynx Bioscience is a first CRO biotech company in Texas region offers next generation omics technologies services for novel and drug repurposed research to diversified clients. Lynx Bioscience has leading scientific experts, state-of-the-art technologies as well as key therapeutic expertise in the areas of neuroscience, oncology, diabetes, pain, inflammation, infectious diseases, respiratory diseases, fibrosis, and rare diseases. Lynx Bioscience is working with pharmaceutical, academic, and biotechnology clients. By leveraging the expertise, Lynx Bioscience intends to support in multi-disciplinary differentiated therapeutics on its systematic, unbiased and comprehensive infrastructure using “OMICS” technologies.

  • High-throughput Screening (HTS)

  • Drug Discovery

  • Drug Target ID

  • Genomics

  • Transcriptomics

  • Proteomics

Our Technology

Lynx bio has expertise to discovery and validation of innovative disease modifying targets across different therapeutic areas.

Our Services

Lynx-HTS platform offers high-quality, and cost-effective high throughput screening services..